Lots of excitement around BOT at present, in light of promising early results. However, they are a long long way from having regulator-approved safe & effective clinical products flying off the shelves. Also, in the biofilm-busting space for therapeutic products, NXS would seem to be well ahead of BOT, imho. Still, money can be made in short term SP sentiment...
Lots of excitement around BOT at present, in light of promising...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $563.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 33.0¢ | 31.0¢ | $1.731M | 5.443M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 606129 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 92444 | 5 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |